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It is highly desirable to predict the progression of Alzheimer’s disease (AD) of patients
[e.g., to predict conversion of mild cognitive impairment (MCI) to AD], especially
longitudinal prediction of AD is important for its early diagnosis. Currently, most existing
methods predict different clinical scores using different models, or separately predict
multiple scores at different future time points. Such approaches prevent coordinated
learning of multiple predictions that can be used to jointly predict clinical scores at
multiple future time points. In this paper, we propose a joint learning method for predicting
clinical scores of patients using multiple longitudinal prediction models for various future
time points. Three important relationships among training samples, features, and clinical
scores are explored. The relationship among different longitudinal prediction models is
captured using a common feature set among the multiple prediction models at different
time points. Our experimental results based on the Alzheimer’s disease neuroimaging
initiative (ADNI) database shows that our method achieves considerable improvement
over competing methods in predicting multiple clinical scores.
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INTRODUCTION
Alzheimer’s disease (AD) imposes heavy social-economic burdens on society (Fan et al., 2008;
Alzheimer’s Association, 2014; Shi et al., 2015), and patients experience tremendous cognitive
decline throughout progression of the AD disease. Tremendous effort have been devoted
to improve the understanding and monitoring of AD progression (Brookmeyer et al., 2007;
Hinrichs et al., 2009; Liu M. et al., 2014; Wang et al., 2014; Jie et al., 2015; Lei et al.,
2015a; Liu et al., 2015; Lei et al., 2016; Zhuo et al., 2016). Modeling disease progression
based on cognitive decline in longitudinal analysis has been widely investigated in the
neuroimaging field (Fan et al., 2008; Davatzikos et al., 2010; Stonnington et al., 2010; Wang
et al., 2010; Hinrichs et al., 2011). In recent decades, neuroimaging-based longitudinal studies
have proven to be an important research direction in characterizing the neurodegenerative
process of AD, where data at multiple time points are often used (Teipel et al., 2007;
Vemuri et al., 2009; Jack et al., 2010; Cuingnet et al., 2011). It has been reported that
researchers are able to study the cognitive decline due to the neurodegenerative property of AD
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with traditional structural magnetic resonance imaging (MRI)
(Davatzikos et al., 2001, 2008; Dickerson et al., 2001; Gaser
et al., 2001; Leow et al., 2006; Jack et al., 2008; Vemuri et al.,
2008; Frisoni et al., 2010; Stonnington et al., 2010; Wang et al.,
2016a), diffusion-weighted MRI (Jin et al., 2015, 2017; Daianu
et al., 2016; Wang et al., 2016b; Wu et al., 2016), and functional
MRI (Yang et al., 2016). In addition, cognitive decline in
the neurodegenerative cognitive measures, e.g., the Alzheimer’s
disease assessment scale cognitive subscale (ADAS-Cog) and the
mini mental state examination (MMSE), can be used to partially
reveal AD progression (Davatzikos et al., 2001, 2008; Dickerson
et al., 2001; Gaser et al., 2001; Leow et al., 2006; Jack et al.,
2008; Vemuri et al., 2008; Frisoni et al., 2010). However, accurate
prediction of AD progression still remains a challenging task due
to the complicated characteristic of AD progression.
The first challenge in longitudinal studies for AD diagnosis
is dimensionality of the data, which is usually much higher
than the available number of samples. To address this issue,
researchers have developed various feature selection models for
different clinical scores (e.g., ADAS-Cog and MMSE) to identify
disease-related biomarkers among multiple time points (Yuan
and Lin, 2006; Zhang et al., 2012; Zhou et al., 2013). Among these
methods, Lasso and its variants are the most popular techniques
for feature selection (Tibshirani, 1996; Guyon et al., 2002; Guyon
and Elisseeff, 2003; Yuan and Lin, 2006; Wang et al., 2010). For
instance, (Wang et al., 2010), linear regressionmodels are applied
in high-dimensional pattern recognition problems not only to
estimate the stage of AD, but also to construct a stable model.
Adaptive regional feature extraction is applied to this model for
the prediction of regression variables.
The second challenge is understanding the underlying
relationship between features, subjects, and clinical scores at
different time points. This relationship is seldom considered even
though many longitudinal studies show promising predictive
power in AD progression prediction. This relationship could
provide inherent high-level information that is useful for
studying AD. Therefore, modeling and utilizing this relationship
could enhance the learning performance in predicting AD
progression.
To tackle the above-mentioned challenges, several methods
such as the group Lasso (Yuan and Lin, 2006), the temporally
constrained group Lasso (TGL, Caroli and Frisoni, 2010;
Jack et al., 2010), and the convex fused sparse group Lasso
(cFSGL, Zhou et al., 2013) incorporated cognitive progression
information into linear regression models to predict disease
progression. Evidently, multi-task learning methods using
intrinsic information achieve better performance than single-
task learning methods (Liu et al., 2012, 2015; Zhu et al., 2014a;
Jie et al., 2015), and this learning framework has shown great
success in predicting ADAS-Cog and MMSE due to its good
generalization capabilities (Zhang et al., 2011; Zhu et al., 2014a).
For example, Zhang and Shen (Zhang et al., 2011) proposed
a joint regression and classification scheme to understand the
mechanism of AD. This method was further improved by Zhu
et al. using a feature and variable graph matching method to
jointly identify AD status and predict clinical scores (Zhu et al.,
2014a). The inter-modality constraints described by Liu et al.
were also included in a multi-task learning framework for AD
diagnosis (Liu F. et al., 2014). Despite promising performance
achieved by these methods, most existing methods fail to take
advantage of the cognitive progression frommultiple time points
among features, subjects, and clinical scores. This mission is
undesirable in longitudinal analysis and follow-up studies.
To incorporate cognitive progression relationships,
longitudinal analysis has been widely explored to model
cognitive progression and to exploit the associated imaging
markers and cognitive changes across all time points (Misra
et al., 2009; Davatzikos et al., 2010; Stonnington et al., 2010;
Hinrichs et al., 2011; Zhang et al., 2012; Zhang and Shen,
2012; Zhou et al., 2013). For instance, Zhou et al. (2013)
integrated temporal smoothness into their method using multi-
task learning techniques to identify biomarkers for disease
progression. Remarkable performance is achieved based on
temporal-relational constraints and later-time constraints,
in which each task is treated separately using a single baseline
feature for predicting future-time-point score. Huang et al. (2015,
2016) proposed an improved random forest framework and took
advantage of the longitudinal information at multiple time points
to further improve the accuracy of AD score prediction. Using
complementary information, such as MRI data and clinical
scores, is desirable as it might uncover important imaging
biomarkers. Zhang et al. found that longitudinal analysis is
effective for mild cognitive interference (MCI) prediction
(Zhang and Shen, 2012) and proposed the utilization of MRI
features at multiple time points with temporal smoothness
regularization (Zhang et al., 2012). This method outperformed
competing methods, because the disease pattern is better
revealed by comprehensive cognitive progression information
as compared to methods using only the baseline features. In
addition, the AD progression prediction problem in Wang
et al. (2012) was addressed by a high-order multi-task learning
method that exploits the temporal correlations in imaging
and cognitive data with a structured sparsity inducing term.
Promising predictive power is achieved via multiple time point
features, and the clinical scores are learned independently. This
arrangement is undesirable as correlation of the clinical score is
ignored.
Most existing methods ignore the relationship among
different features, subjects, and clinical scores. Furthermore, the
relational information is seldom studied even though there is
a strong correlation between the clinical scores and MRI data
(Gaser et al., 2001; Leow et al., 2006). Moreover, most of the
previous studies only focused on one or two types of relationships
without considering the cognitive decline at different time points.
The integration of this type of information would better identify
the spatial patterns of brain atrophy because the associated
feature patterns and the specific patterns of the neighboring
time points are highly correlated. It has been also demonstrated
in literature (Zhu et al., 2014a; Jie et al., 2015) that multiple
relationships between feature-feature and subject-subject boost
diagnosis performance.
Intuitively, information from clinical scores and subjects at
multiple time-points can play an important role in identifying
temporal patterns in longitudinal analysis. In this paper, a
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new multi-task joint feature learning method is developed to
exploit the intrinsic relation of the data to boost performance of
disease prediction.Manifold learning and discriminative learning
theories have achieved remarkable performance by incorporating
(Stanciu et al., 2014; Zhu et al., 2014b; Jie et al., 2015; Lei
et al., 2015b; Zhou et al., 2015). Therefore, we explore temporal
smoothness and multi-relation graphs among different patterns
and cognitive measures to uncover human brain variations for
better diagnosis of AD progression. Specifically, we define a
novel objective function to impose multi-relation information.
A group sparsity regularizer is used to jointly select a small
number of specific features across different time points. We also
incorporate multi-relation smoothness regularization to capture
the relationship among features, subjects, and clinical scores.
After the selection of longitudinal feature, the final selected brain
regions are employed for clinical score prediction using multi-
kernel support vector regression (SVR, Chang and Lin, 2011). To
the best of our knowledge, there is no existing sparse model that
incorporates multi-relation smoothness in its objective function
to estimate the clinical scores (e.g., ADAS-Cog and MMSE). In
addition, our method focuses on multiple relationships, which
has obvious advantages over existing methods that only exploit
feature or sample relationships. It is worth noting that we
need to observe the behavioral changes in patients’ condition
over time in order to model disease progression. However, it
is difficult to extract huge amount of information from data
that is collected from multiple time points. Therefore, we utilize
the aforementioned relational constraints to build a robust
regression model by selecting the best and most relevant features
to predict patient’s clinical behavior at multiple future time
points.
In this paper, we propose a joint learning procedure
for multiple longitudinal predictions of AD progression by
exploiting their inherent relationships. In particular, we propose
three novel regularization terms (each modeling a set of
crucial relationships at different time points), and incorporate
these regularizers in a multi-task sparse feature selection
model. We also introduce a specifically designed loss function
to jointly predict the patients’ clinical scores at multiple
future time points, thus condensing the common information
shared by data from different time points and permitting
the selection of the most meaningful features for multiple
prediction tasks. We evaluate our method using the Alzheimer’s
disease neuroimaging initiative (ADNI) (http://adni.loni.usc.
edu/) database (Alzheimer’s Association, 2014), and our method
achieves promising results in estimating multiple clinical scores
at multiple future time points using only baseline data. For the
ADNI baseline, a total of 445 subjects—91 with AD, 202 with
mild cognitive impairment (MCI), and 152 cognitively normal
controls (NCs) are investigated in our study to predict the ADAS-
Cog/MMSE scores for the next 2 years because the subjects
already have completedMRI and clinical score data. In this work,
we focus on only using suitable data instead of all the data from
the ADNI database to study of disease progression.
Our extensive experimental results show that the proposed
joint learning framework obtains state-of-the-art performance
for future ADAS-Cog/MMSE score prediction. We observe that
the hippocampal formation, amygdala, temporal pattern, and
uncus demonstrate the most definitive patterns in predicting
clinical scores at all-time points.
MATERIALS AND METHODS
Materials
Our investigation is based on data obtained from the ADNI
database (Alzheimer’s Association, 2014), which was created and
updated since 2004. This 6-year study is funded $60 million
from the public and private sectors, which include the National
Institute on Aging, the National Institute of Biomedical Imaging,
and Bioengineering, and the Food and Drug Administration.
The principle goal of ADNI is to verify that serial MRI and
positron emission tomography (PET) images, along with other
biological markers, clinical, and neuropsychological assessment
can be used to measure the progression of MCI and early AD.
The determination of sensitive and specific markers of very early
AD progression is intended to aid researchers and clinicians to
develop new treatments andmonitor their effectiveness, as well as
to lessen the time and cost of clinical trials. ADNI is the collective
effort of many co-investigators from a broad range of academic
institutions and private corporations, and subjects have been
recruited from over 50 sites across the US and Canada. 800 adults
aged 55–90 were recruited to participate in this research, which
includes approximately 200 cognitively normal older individuals
followed for 3 years, 400 people with MCI followed for 3 years,
and 200 people with early AD followed for 2 years. For up-to-date
information, please refer to http://www.adni-info.org.
Subjects and Pre-processing
The general eligibility criteria of ADNI are briefly described
in the following. Subjects between 55 and 90 years of
age who have a study partner to provide an independent
evaluation of functioning were selected. Patients taking certain
psychoactive medications were excluded. There are three general
inclusion/exclusion criteria: (1) The range of MMSE scores of
healthy subjects (non-depressed, non-MCI, and non-demented)
is 24–30; (2) The range of MMSE scores of MCI subjects
is also between 24 and 30. The subjects having objective
memory loss were measured with education adjusted scores
using the Wechseler memory scale logical memory II, a CDR
of 0.5, an absence of significant levels of impairment education
adjusted scores fall between 20 and 26, and satisfy the National
Institute of Neurological and Communicative Disorders and
Stroke, and the Alzheimer’s Disease and Related Disorders
Association (NINCDS/ADRDA) criteria for probable AD. The
study subjects gave written informed consent at the time of
enrollment for imaging and genetic sample collection and
completed questionnaires approved by each participating site
TABLE 1 | Statistical information of clinical scores.
Clinical scores Mean Median Min Max
MMSE 12.02 10 0 59
ADAS-Cog 26.27 28 5 30
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Institutional Review Board (IRB). Table 1 gives the detailed
ADAS-Cog and MMSE information of the subjects used in our
study.
The pre-processing of feature extracted from the ROI regions
have been widely applied in the literature (Liu et al., 2012, 2015;
Zhu et al., 2014a; Jie et al., 2015). For our method, pre-processing
was first applied to the T1-weighted MRI brain images of each
subject, and then skull stripping was performed to clean the skull.
The cerebellum was removed by warping a labeled Jacob atlas to
the skull-stripped image (Wang et al., 2014). Segmentation by the
FAST method (Zhang et al., 2001) was then applied to segment
the brain images into three tissues, which include white matter
(WM), gray matter (GM), and cerebrospinal fluid (CSF). After
segmentation, the brain image was nonlinearly registered with a
HAMMER tool (Shen andDavatzikos, 2002). The features used in
this study include the volume intensity extracted from the region
of interest (ROI) of different brain regions (Zhang et al., 2011).
Specifically, the brain image of each subject was partitioned into
93 ROIs by atlas warping, and the volume of GM tissue of each
ROI was extracted as a feature. Similar to the study in Wee et al.
(2012), the obtained features were normalized to facilitate disease
diagnosis and prognosis.
Notation and Problem Statement
For this work, capital bold letters denote matrices, small bold
letters denote vectors, and non-bold letters denote regular
variables. Let X ∈ RS×F denote the data of S different subjects,
where each subject is represented by an F-dimensional feature
vector from the baseline MRI image. Let X denote the data
generated from baseline time point. We denote xu,: and x:,v as the
u-the row vector and the v-th column vector of X, respectively.
Let Y =
{
Y(t) ∈ RS×C, t = 1, . . . ,T
}
denote C types of clinical
cognitive scores (e.g., ADAS-Cog and MMSE) for S subjects
at T time points, where Y(t) ∈ RS×C is the corresponding
clinical scores at the t-th time point for S subjects. Let W ={
W(t) ∈ RF×C, t = 1, . . . ,T
}
as denote the set of weight matrices
that map the original features to clinical scores, where W(t)
represents the weight matrix for the t-th time point.
Our goal is to create a linear regression model to reveal the
longitudinal associations between the original features and the
cognitive trajectories through time, and predict the clinical scores
at multiple future time points from the baseline data (t = 1). This
is illustrated in Figure 1. Each subject’s features are assigned as a
row in the matrix X. By learning the weight vectors in each W(t),
we can reconstruct the corresponding clinical scores in each Y(t),
as explained below.
To simplify the problem and design the objective function,
we unfolded the projected weight matrix by concatenating all
W(t) s as Ŵ =
[
W(1),W(2), · · · ,W(t), · · · ,W(T)
]
∈ RF×CT .
Hence, themodel parameters can be incorporated in the objective
function to extract the common features across different time
points. This unfolded simplified weighting matrix is shown
in Figure 2.
Methodology
A key advantage of longitudinal studies is the ability to observe
the patients’ changes through time, and to effectively utilize the
shared common information in different time points to select
the best set of features for monitoring the progression of MCI
patients and thereafter predicts their future status. There are
three different aspects in which this common information could
be leveraged, i.e., the relationships among features, subjects,
and clinical scores. Intuitively, the pairwise similarities among
features, subjects, and clinical scores should be preserved in
the predictions via the regression model. In this section, we
introduce amethod to incorporate such relation information into
FIGURE 1 | An illustration of the proposed regression model using longitudinal data. X is the input baseline MRI data, Y is the target tensor data, and W is
the weight model projection. For the input X, x-axis represents the features, and y-axis denotes the subjects. For the target tensor data Y, x-axis represents clinical
scores, y-axis represents the subjects, and z-axis denotes the time points. For the model parameters W, x-axis plots the clinical scores, y-axis represents the
features, and z-axis denotes the time points. We want to establish a linear model W between the input X and output Y.
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a multi-task learning framework. Specifically, we define a linear
regression model for each time point using the baseline data as
a single task, and then formulate the global regression model in
a multi-task learning framework with a l2,1 sparsity constraint,
where the above three relational aspects are incorporated
as regularization terms. Figure 3 shows the flowchart of the
proposed method.
To clearly illustrate the relationship among features, subjects,
and clinical scores, we adopted a graph matching technique in
our proposed method, where the feature-feature, subject-subject
and clinical score-clinical score relationships are represented
in terms of graph (shown in Figure 4). In Figure 4A, a
node represents one feature and an edge represents the
FIGURE 2 | The illustration of the unfolded weight matrices. Each row is
correponding to a specific feature vector among different time points, and
each column is corresponding to a clinical score vector at one time point.
relationship between the connected nodes. Figures 4B,C show
the relationship among subjects and among clinical scores,
respectively. In these graphs, the length of an edge between
features (subjects or clinical scores) represents the similarity
among features (subjects or clinical scores), where the similarity
increases with the length of the edge. These graphs are built
based on the information of training data, which are then
used as regularization terms for subsequent multi-task learning
procedure.
Previous studies (e.g., Zhou et al., 2013) revealed the
associations among imaging features and cognitive scores at each
time point separately, under the assumption that each task at each
time point is independent. However, this assumption does not
always hold because clinical scores possess temporal correlation.
In fact, harnessing the temporal correlation could potentially
help predict the clinical cognitive scores. This motivates us to
use a joint learning regression model across all time points,
which would help identify the most relevant imaging markers
for the prediction of cognitive scores. Specifically, we seek to
learn the weight coefficient matrices to uncover the clinical scores
progression, through which the information from each learning
task and the common structures among multiple time points can
be jointly discovered.
To select the most relevant and discriminant features at each
time point, a correlation-induced sparsity model with a least-
squares loss function is proposed. The loss function controls the
prediction error, while the sparsity assumption leads to the least
number of contributing features. As a result, for each time point,
we would select the features that are most correlated with the
actual clinical scores. A general form of the proposed objective
function is defined as below:
min
{W(t) ,t = 1,..,T}
∑T
t = 1
‖ Y(t) − XW(t) ‖
2
F
+ λ1
∑T
t = 1
8
(
W(t)
)
+ λ2‖Ŵ‖2,1, (1)
FIGURE 3 | Flowchart of the proposed method. The MRI data and clinical scores are extracted for longitudinal feature selection, with smoothness regularization
(i.e., feature-feature, subject-subject, and clinical score-clinical score relation guided regularizers) and a group sparsity induced regularization. After longitudinal feature
selection, the feature dimension is reduced, and the selected features are employed to build ADAS-Cog and MMSE regression models for prediction.
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FIGURE 4 | Illustration of relations among (A) features, (B) subjects, and
(C) clinical scores, where a node means a vector of (A) feature, (B) subject,
(C) clinical score, respectively, and an edge denotes the distance between the
nodes.
where ‖ · ‖ 2F is the Frobenius norm of a matrix, W is
the coefficient weight matrix, λ1 and λ2 are the regularization
parameters. The last term in Equation (1) is a group regularizer
to uncover the correlation among different features and jointly
select features for multiple tasks, which is defined as ‖ Ŵ ‖2,1=∑F
i = 1 ‖ ŵi,:‖2, where ŵi,: is the i-th row vector of Ŵ, and ‖ · ‖
2
F
is l2,1-norm. It is worth noting that l2,1 -norm computes the sum
of the l2 -norm of each row of Ŵ, which enforces many rows to
be zero, and hence it is suitable for feature selection. Features
corresponding to those non-zero rows in Ŵ are regarded as
the most predictive features in subsequent learning models.
The second term 8(W(t)) is our proposed regularizer, which is
comprised of multiple parts corresponding to three relationships
among features, among subjects, and among clinical scores. To
define the proposed regularization term, 8(W(t)), the “feature-
feature,” the “subject-subject,” and the “clinical score-clinical
score” relationships at each different time point are incorporated.
We use the idea of Laplacian matrices and graphs to obtain the
similarity in the local structures (Belkin and Niyogi, 2003). In
the rest of this section, we explain it in detail and discuss all its
characteristics.
The “feature-feature” relation information is imposed as the
relationship between columns of the input matrix X, and is
reflected in the relation between corresponding rows in the
coefficients weight matrix W(t). Hence, the widely used graph
Laplacian (Hinrichs et al., 2009; Wang et al., 2012; Zhu et al.,
2013) is leveraged. To measure the similarity between the u-th
and the v-th features of X. in the original feature space, we use
the heat kernel defined as below:
fuv = exp
(
− ‖ x
:,u − x:,v ‖
2
2
)
, (2)
where x
:,u is the u-th column of the input data X. Based on
the similarity, we develop the first feature-feature relation based
regularization term as
Rf
(
W(t)
)
=
∑F
u,v = 1
fuv ‖ w
(t)
u,: − w
(t)
v,: ‖
2
2, (3)
wherew
(t)
u,: is the u-th row ofW
(t) at time point t. Thus, the highly
correlated features produce large weights in the above sparsity
regularization.
The second regularization is based on the “subject-subject”
relation graph. We know that the output clinical scores of similar
subjects should be similar. Therefore, similar to the previous
term, we use a heat kernel to exploit the “subject-subject”
similarities and define the similarity between the m-th and the
n-th subject as
φmn = exp
(
− ‖ xm,: − xn,:‖
2
2
)
, (4)
where xm,: is the m-th row of input X. Here, “subject-subject”
relation regularizer is defined as
Rs
(
W(t)
)
=
∑S
m,n = 1
φmn ‖xm,:W
(t) − xn,:W
(t)‖22. (5)
The last regularization is based on the “clinical score-clinical
score” relation. For each subject’s feature vector xp,: in our
regression framework, different sets of weight coefficients are
used to regress the output clinical scores y
(t)
:,p. In other words, the
elements in each column of W(t) are related to the elements in
each column of Y(t) through the feature vectors. As a result, if two
clinical scores are correlated, the corresponding weight columns
in matrix W(t) should be correlated too. Similarly, we use a heat
kernel to exploit the “clinical score-clinical score” relation. The
similarity between the p-th clinical score and the q-th clinical
score is defined using a heat kernel as
ψpqt = exp
(
− ‖y
(t)
:,p − y
(t)
:,q‖
2
2
)
, (6)
where y
(t)
:,p is the p-th column vector of Y
(t). To this end, we define
the clinical score relational regularization term as
Rc
(
W(t)
)
=
∑C
p,q = 1
ψpqt‖w
(t)
:,p − w
(t)
:,q‖
2
2. (7)
Therefore, our proposed joint learning model using the relation
information, as discussed above, is
min
{W(t),t = 1,..,T}
∑T
t = 1
‖ Y(t) − XW(t) ‖2F + λ1
∑T
t = 1
(
Rf
(
W(t)
)
+ Rs
(
W(t)
)
+ Rc
(
W(t)
))
+ λ2 ‖Ŵ ‖2,1 . (8)
Using Equation (8), we incorporate three types of relationship
data at multiple time points into a unified objective function. This
method is referred as the simultaneous multi-relation temporally
constrained learning (SMTL). To the best of our knowledge,
this is the first work to simultaneously incorporate multi-
relation information such as “feature-feature,” “subject-subject,”
and “clinical score-clinical score” in fused regularizations, which
is difficult to solve in current sparse models. In addition, no
previous studies jointly apply the multi-relation information
across multiple time points as additional regularizers.
Motivated by Zhu et al. (2013), the optimization problem in
Equation (8) could be solved in an alternative way (i.e., finding
the optimal solution for one variable while the others are fixed).
The optimization steps are discussed in the following section.
After selecting themost meaningful features, we use a SVRmodel
to predict the clinical scores of patients at multiple future time
points. Considering how AD changes over time, our algorithm
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benefits from a joint multi-task learning framework, in which
multiple relationships are introduced as regularization terms
to take advantage of the local structure similarity in the data.
Because of the sparsity property of the l2,1 -norm regularization
on weight vectors, the optimal weights contain some zero or close
to zero row vectors. Structured sparsity is then imposed through
penalizing all the regression coefficients corresponding to each
single feature, at multiple time points. Thus, the most distinctive
and predictive features will have similar large weights across all
time points.
Optimization Algorithms
Although our objective function is convex, it is difficult to solve
because regularization terms are based on non-smooth sparsity-
inducing norms in the objective function (Zhu et al., 2013,
2014a). l2,1 norm minimization is more challenging to solve
than the l1 -norm minimization problem. As most existing
optimization algorithms are too computation costly to solve our
problem (Wee et al., 2012; Zhang and Shen, 2012), an efficient
iterative algorithm is developed in this work.
In the similarity measurement, a Laplacian graph at each time
point is built based on a diagonal matrix and formulated as:
D
f
= fuv, Ds = φmn, D
(t)
c = ψpqt . Let Sf , Ss and S
(t)
c denote the
summation of the diagonal entry of D
f
,Ds, and D
(t)
c , respectively.
The graph Laplacian L
f
for the feature space at each time point
is: L
f
= D
f
− S
f
. Similarly, we have the Laplacian graph for the
subject and clinical score, Ls = Ds − Ss and L
(t)
c = D
(t)
c − S
(t)
c ,
respectively. As any regularization term Rs(W
(t)) can be
reformulated as Rf (W
(t)) = Tr
(
(W(t))
T
L
f
W(t)
)
,Rs(W
(t)) =
Tr
(
(W(t))
T
LsW
(t)
)
,Rc(W
(t)) = Tr
(
(W(t))
T
L
(t)
c W
(t)
)
.
Assuming LD is Laplacian graph built based on a diagonal
matrix of Ŵ, the objective is first reformulated as:
J(W(t)) = min
{W(t) ,t = 1,..,T}
∑T
t = 1
‖ Y(t) − XW(t)‖2F
+ λ1
∑T
t = 1
Tr
(
(W(t))
T
Lf W
(t) +
(
XW(t)
)T
Ls XW
(t)
+W(t)L(t)c (W
(t))
T
)
+ λ2Tr
(
ŴTLDŴ
)
, (9)
where LD is Laplacian graph built based on a diagonal matrix
of Ŵ. The optimal solution of W(t) is obtained by taking the
derivative of the objective function with respect to W(t).
By taking the derivative of the objective function in Equation
(8) with respect to W(t) and set to 0, we obtain:
XTX− X(Y(t))
T
+ λ1
(
Lf W
(t) + XTLs XW
(t) +W(t)L(t)c
)
+ λ2LD W
(t) = 0. (10)
We can rewrite Equation (10) as
(XTX+ λ1Lf + λ1X
TLs X+ λ2LD)W
(t) +W(t)
(
λ1L
(t)
c
)
= X
(
Y(t)
)T
. (11)
This equation is regarded as Sylvester equation and solvable in
the closed form Zhu et al. (2014a) using
AW(t) +W(t)B = Q, (12)
where A = XTX + λ1Lf + λ1X
T
Ls X + λ2LD, B = λ1L
(t)
c and
Q is X(Y(t))
T
, W(t), (1 ≤ t ≤ T) can be obtained by solving the
Sylvester equations (Zhu et al., 2014a) when the time t changes
from 1 to T.
Since Lf , Ls, L
(t)
c , and LD are obtained from W
(t) and are
dependent of W(t), an iterative optimization is proposed to
efficiently obtain the global solutions of W(t), (1 ≤ t ≤ T) (Zhu
et al., 2013). The solution of W(t) for1 ≤ t ≤ T is summarized
in Algorithm 1. The iterative optimization method updates W(t)
until the objective function converged.
EXPERIMENTAL RESULTS
A 10-fold cross validation strategy is employed to avoid any bias
introduced in the data and experiments. A set of 445 subjects
comprising of 91 NC, 202 patients with MCI, and 152 AD
patients are included in our study. We also used subjects from
the ANDI database with T1-weighted MRI data from a 1.5 T
scanner. The entire set of subjects is equally partitioned into
10 subsets, and the subjects of one subset are selected as the
testing samples and the subjects in the remaining nine subsets
are used for training regression models. In our experiments, the
regression model is implemented using the LIBSVM toolbox
with default parameters, and a linear kernel is adopted after
normalizing each feature vector into a unit norm. In the pre-
processing step, the features are z-normalized by removing their
mean and dividing the result by its standard deviation. The two
cognitive measurements, ADAS-Cog and MMSE, are computed
Algorithm 1 | An iterative algorithm to solve the optimization problem in
Equation (8)
Input: Baseline MRI training data of S subjects and F dimensional feature:
X ∈ RS×F
T time points clinical scores of S subjects and C dimensional clincial
score vector: Y =
{
Y(t) ∈ RS×C, t = 1, . . . , T
}
Parameters:
regularization paramters and iteration times
Output: Weight projection matrix: W =
{
W(t) ∈ RF×C, t = 1, . . . , T
}
Set iteration r = 0 and initialize W(t) ∈ RF×C according to the linear
model for each time point;
Initialization: Ŵ(0) = [W(1),W(2), . . . ,W(t), . . . ,W(T )]
Repeat
for t = 1 to T
Calculate Lf, Ls, L
(t)
c and LD, according to the above definitions;
Update Ŵ
(t)
r by solving the Sylvester problem in equation (13);
End for
Ŵ
(t)
r+1 = [W
(1),W(2), . . . ,W(t), . . . ,W(T )];
r = r+1;
until (r = 50 or Ŵ−W2 < 10
–6)
Return W(t), (1 ≤ t ≤ T )
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from the MRI data collected at four different time points.
The experimental setup from Zhou et al. (2013) is adopted.
The regularization parameters in the feature-selection model of
Equation (8) (i.e., λ1 and λ2) are determined by performing
another round of cross-validation on the training data.
Figure 5 summarizes the objective function values at different
iterations. The objective function values monotonically decrease
as the number of iterations increases, which is consistent with
our convergence analysis. The objective value quickly converged
after a few iterations, which demonstrates the effectiveness of the
proposed optimization method and the efficacy of our feature
selection algorithms.
Extensive experiments are performed to evaluate the
effectiveness of the proposed feature selection method. Two
regression tasks are constructed to predict the changes in ADAS-
Cog and MMSE for the baseline and a two-year follow-up study.
The widely used Pearson’s correlation coefficient (Corr) and
root-mean-square error (RMSE) metrics are used to measure
performance (Duchesne et al., 2009; Ito et al., 2010; Stonnington
et al., 2010; Zhou et al., 2013).
ADAS-cog and MMSE Prediction Results
Figure 6 shows the scatter plots of the estimated ADAS-Cog
scores vs. the actual ADAS-Cog scores obtained with the
proposed method at baseline, 6, 12, and 24 months. Figure 7
shows the scatter plots of the predicted MMSE vs. the actual
MMSE scores obtained with the proposed method at baseline, 6,
12, and 24 months. The linear model adopted in the proposed
method is illustrated with a red line, and the perfect regression
method is shown by a green line for comparison. Although
predicting future clinical scores is quite challenging, it is evident
that our proposed method achieves remarkable results in terms
of Corr and RMSE results. Similar to the previous studies (Zhang
and Shen, 2012; Zhang et al., 2012; Zhou et al., 2013), we observed
that predicting early and changes of MCI up to 1 year is more
difficult than later time points as less distinct information is
available to separate early MCI. The low correlation values in
the early time periods are mainly due to the failure to detect
progression from MCI to early AD, and it is even harder to
uncover essential changes of brain regions in early MCI. Our
experimental results show that the proposed multiple time point
FIGURE 5 | Scatter plots of predicted vs. actual ADAS-Cog values at different time points; (A) Baseline (B) 6 Months (C) 12 Months (D) 24 Months. The red
line in each figure is a reference of perfect correlation. The green line is the regression line by the proposed model. The closer between the regression line and
reference line, the better performance the proposed method can achieve. A high correlation is observed for ADAS-Cog prediction at each time point.
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FIGURE 6 | Scatter plots of predicted vs. actual MMSE values at different time points; (A) Baseline (B) 6 Months (C) 12 Months (D) 24 Months. The red line
in each figure is a reference of perfect correlation. The green line is the regression line with the proposed model. The closer between the regression line and reference
line, the better prediction the proposed model can achieve. A high correlation is observed for MMSE prediction at each time point.
joint learning with multiple relationships information is better
at predicting ADAS-Cog and MMSE scores than single-task
learning and the separate learning methods. We also address
the problem of predicting the future cognitive decline of MCI
subjects.
Algorithm Comparison
A comparison of our proposed method with three feature
selection methods, namely, Lasso, temporal group Lasso (TGL,
Zhang et al., 2012), and convex fused temporally constrained
group Lasso (cFSGL, Zhou et al., 2013) is performed. Figure 8
shows the performance of these methods on predicting ADAS-
Cog/MMSE scores at baseline (T1), 6 months (T2), 12 months
(T3), and 24 months (T4). We also present the detailed
algorithm comparison results in terms of Corr and RMSE in
Table 2. Our experimental results demonstrate that the proposed
method performs better than the separate learning method in
predicting ADAS-Cog and MMSE scores. We observed that the
prediction of the changes of early and first year clinical score
is significantly harder than the later time points since there
is less distinct information available for the earlier prediction,
which was also confirmed by previous studies (Zhang et al.,
2012; Zhou et al., 2013). The main reason for low correlation
in the early time frame is that there is not sufficient time for
MCI to progress to early AD, thus it is more challenging to
uncover the essential changes of brain regions in early MCI.
Our proposed method achieves stable and promising results
for both ADAS-Cog and MMSE prediction, and outperforms
several state-of-the-art methods (Zhang et al., 2012; Zhou
et al., 2013). From the experimental results, the promising
prediction results clearly suggest the effectiveness of the proposed
method.
Next, we compare different sub-groups containing all subjects
including AD, MCI, NC (ALL), and only MCI patients
(MCI). Figure 9 presents the detailed comparison results of
the different sub-groups for ADAS-Cog and MMSE prediction.
Since our method is jointly learned, better results are observed
from the ALL group. This group provides the opportunity
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for the proposed algorithm to discover multi-relationship
information usingmulti-task learning.Table 3 shows the detailed
comparison of the state-of-the-art methods. The proposed
FIGURE 7 | Objective value as a function of the iteration number on the
ADNI dataset.
method with multi-relationship information obtains remarkable
results, especially for the prediction of later time points for both
ADAS-Cog and MMSE, which are consistent with the findings in
the previous publications as well (Zhang et al., 2012; Zhou et al.,
2013).
Top Selected Brain Regions
The hippocampus plays an important role in identifying brain
conditions through AD modeling and measuring the cognitive
outcomes such as ADAS-Cog and MMSE. By extracting features
from the associated brain regions, the multi-task mechanism
accounts for the hippocampus region’s sensitivity in cognitive
score prediction via MRI baseline data. MCI is characterized by
the temporal lobe neocortical regions during dementia decline.
Therefore, it is of great significance to find biomarkers for
the diagnosis of AD. In this section, we investigate multiple
regression variables and their relationships with brain variables
such as ADAS-Cog and MMSE. Based on the cross validation,
the top predictive regions were selected in terms of the frequency
of feature appearance. Figure 10 shows the top 30most predictive
brain regions with the highest weights for ADAS-Cog andMMSE
predictions of our proposed and cFSGL methods, where darker
colors denote larger weights and vice versa. The most predictive
FIGURE 8 | Comparison of ADAS-Cog and MMSE prediction results by our proposed SMTL method and three feature selection methods: Lasso, TGL,
and cFSGL, using Corr and RMSE measurement; (A) ADAS-Cog prediction results in terms of Corr (B) ADAS-Cog prediction results in terms of RMSE (C) MMSE
prediction results in terms of Corr. (D) MMSE prediction results in terms of RMSE.
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Table 2 | Comparison of ADAS-Cog and MMSE prediction results by our proposed SMTL method and three feature selection methods: Lasso, TGL, and
cFSGL, using Corr and RMSE measurement.
ADAS–Cog MMSE
Lasso TGL cFSGL SMTL Lasso TGL cFSGL SMTL
Baseline Corr 0.32 ± 0.08 0.49 ± 0.08 0.58 ± 0.08 0.77 ± 0.05 0.51 ± 0.09 0.56 ± 0.12 0.64 ± 0.08 0.75 ± 0.08
M06 Corr 0.48 ± 0.07 0.50 ± 0.07 0.59 ± 0.05 0.78 ± 0.04 0.49 ± 0.07 0.48 ± 0.10 0.63 ± 0.10 0.79 ± 0.10
M12 Corr 0.46 ± 0.12 0.52 ± 0.09 0.62 ± 0.05 0.79 ± 0.04 0.52 ± 0.06 0.57 ± 0.08 0.64 ± 0.12 0.79 ± 0.12
M24 Corr 0.57 ± 0.08 0.53 ± 0.08 0.69 ± 0.05 0.84 ± 0.04 0.61 ± 0.05 0.58 ± 0.05 0.65 ± 0.05 0.83 ± 0.06
Baseline RMSE 5.19 ± 0.33 5.53 ± 0.32 5.20 ± 0.33 3.81 ± 0.45 2.25 ± 0.20 2.30 ± 0.24 2.24 ± 0.21 1.75 ± 0.20
M06 RMSE 5.48 ± 0.62 5.90 ± 0.65 5.48 ± 0.63 4.36 ± 0.46 2.75 ± 0.31 2.85 ± 0.33 2.76 ± 0.32 2.31 ± 0.29
M12 RMSE 6.25 ± 0.58 6.74 ± 0.63 6.24 ± 0.59 4.91 ± 0.56 3.42 ± 0.49 3.59 ± 0.52 3.42 ± 0.50 2.48 ± 0.40
M24 RMSE 7.95 ± 1.20 7.81 ± 1.39 7.96 ± 1.23 6.00 ± 1.00 4.05 ± 0.58 4.48 ± 0.82 4.04 ± 0.58 3.00 ± 0.38
FIGURE 9 | Comparison of ADAS-Cog and MMSE prediction models in terms of both Corr and RMSE for all subjects including AD, MCI, and NC (ALL)
and only MCI patients (MCI); (A) ADAS-Cog prediction results in terms of Corr (B) ADAS-Cog prediction results in terms of RMSE (C) MMSE prediction.
brain regions, namely, the hippocampus and amygdala, are
commonly selected for regression tasks. Most of the commonly
selected top regions such as hippocampal formation, amygdala,
and uncus regions proved to be sensitive and provides AD
biomarkers in many studies (Zhang et al., 2012; Zhou et al.,
2013).
Biomarkers from different time-points are consistently
identified, and important MRI patterns are localized, which
suggest that the MRI biomarkers are able to predict the ADAS-
Cog and MMSE results effectively. The distinctive and important
biomarkers selected in our study included the hippocampal
formation, amygdala, middle temporal lobe, uncus, and corpus
callosum. The hippocampus is the most important region
affecting AD as it possesses significant structural lesions (Convit
et al., 2000; Laakso et al., 2000; Wolf et al., 2003; Del Sole
et al., 2008; Knafo et al., 2009; Derflinger et al., 2011; Poulin
et al., 2011; Ota et al., 2014). Both cFSGL and proposed method
selected the important biomarkers for AD diagnosis, while our
proposed method identifies more stable and related features
for the clinical score measurement. Moreover, the distinctive
information selected by the proposed method is more promising
for AD modeling than the cFSGL method, due to the joint
learning adopted in a multi-task framework, and weights for
both ADAS-Cog and MMSE are considered jointly, rather than
separately. The common and shared high-level information
of ADAS-Cog and MMSE scores can be further explored for
disease progression modeling. As a result, the most predictive
brain regions such as the hippocampus, amygdala, and temporal
patterns are commonly selected in our regression models. The
identified brain regions are consistent across multiple time
points. The weights for ADAS-Cog and MMSE have similar
patterns as well. Moreover, our proposed method confirms that
Frontiers in Aging Neuroscience | www.frontiersin.org 11 March 2017 | Volume 9 | Article 6
Lei et al. Longitudinal Analysis for Disease Progression
Table 3 | Algorithm comparisons of the proposed method with the related works for ADAS-Cog and MMSE prediction.
Method Target Subject Feature Result (Corr)
Duchesne et al., 2009 M12 MMSE 75 NC, 49 MCI, 75 AD Baseline MRI,
age, gender, years of education
MMSE: 0.31 (p = 0.03)
Stonnington et al., 2010 Baseline
ADAS-Cog and
MMSE
Set 1:73 AD, 91 NC
Set 2: (ADNI) 113 AD, 351 MCI,
122 NC
BaselineMRI, CSF MMSE Set1: 0.7 (p < 10e-5)
Set 2: 0.48 (p < 10e-5) ADAS-Cog
Set 2: 0.57 (p < 10e-5)
Zhang et al., 2012 Baseline,M06,M12,M24
ADAS-Cog, MMSE
ADNI: 91 AD, 202 MCI, 152 NC Baseline,M06, M12, M24 MRI Average MMSE: 0.613 (p < 10e-5)
Average ADAS-Cog: 0.639 (p < 10e-5)
Proposed Baseline, M06, M12, M24
ADAS-Cog, MMSE
ADNI: 91 AD, 202 MCI, 152 NC Baseline MRI Average MMSE: 0.7538 (p < 10e-5)
Average ADAS-Cog: 0.7875 (p < 10e-5)
AD, MCI, and NC denote Alzheimer’s disease patients, mild cognitive impairment patients, and normal controls, respectively.
FIGURE 10 | The most predictive regions identified by (A) Proposed and (B) cFSGL method (Zhou et al., 2013). Note that the proposed method learns
ADAS-Cog/MMSE jointly, while cFSGL learns them separately.
the hippocampus and amygdala are highly important for studies
on AD.
In general, higher weights lead to the selection of better
features, namely, large weight values correspond to the
effectiveness of features to characterize the brain atrophy through
quantitative measurements. The experiments on progression
from MCI to AD produce similar results from predicting AD
and NC in the training steps. ADAS-Cog and MMSE predictions
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FIGURE 11 | The probability feature map for predicting the scores.
share common effective information. Other feature selection
methods such as cFSGL demonstrate different patterns. As shown
in the stable feature selection results, our method generally
obtains more stable features for predicting both ADAS-Cog and
MMSE scores at multiple time points. In general, our method
outperforms the competing methods, which is also demonstrated
in the probability map shown in Figure 11. The probability map
further confirms that the hippocampus and amygdala are highly
correlated with AD. The features extracted from these regions
have high predictive power for the ADAS-Cog and MMSE
prediction.
As illustrated in Figure 12, the most effective features for
predicting ADAS-Cog and MMSE across all time points are,
namely, angular R, right hippocampal formation, right temporal
lobe WM, left uncus, left middle temporal, right periirhinal
cortex, left periirhinal cortex, left inferior temporal, and left
temporal. Our findings are consistent with many previous
studies which determined the amygdala, hippocampal formation,
angular, and uncus are the most predictive biomarkers for AD
characterization (Convit et al., 2000; Laakso et al., 2000; Wolf
et al., 2003; Del Sole et al., 2008; Knafo et al., 2009; Derflinger
et al., 2011; Poulin et al., 2011; Ota et al., 2014).
DISCUSSIONS AND CONCLUDING
REMARKS
These relationships could provide inherent high-level
information on AD progression, therefore modeling and
utilizing such relationship information can enhance the learning
performance of AD progression prediction. Although there are
a myriad of progression models available, such as regression
and survival model (Wang et al., 2010), we used a popular SVR
model due to its desirable properties. The accurate prediction of
ADAS-Cog and MMSE scores is essential in modeling disease
progression of AD, and to assist clinical assessment. It is shown
that clinical scores are highly correlated with ventricle change,
shape, hippocampal, and gray matter volume loss. Because
the medial temporal lobe and brain atrophy pattern are highly
related to MMSE, the correlation should be utilized for clinical
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FIGURE 12 | Top 10 most predictive brain regions for predicting the cognitive measurements.
score prediction. Apart from feature selection, clinical model
and statistical analysis extract diagnostic information and learn
large-scale medical imaging based features. The advantages of
our models include discrete timestamps at irregular intervals
for modeling the disease progression of AD, and the greater
interpretability of our model due to the improvement in the
selection of distinct features.
Even though promising prediction results were obtained in
our study, there are still some limitations in the proposed feature
selection method. First, only a single modality is used. If multiple
modalities were available (such as PET, DTI, APOE, andCSF), the
predictive power could be possibly enhanced. Second, all subjects
should have complete feature values with no missing data. This
would be challenging to achieve with larger experiments and
more subjects. Future research can be conducted to investigate
the issues associated with missing data. Third, we only investigate
the ADAS-Cog and MMSE predictions. It is possible to extend
this method to predict the sub-scores of clinical tests and other
regression variables, such as the clinical dementia rating scale
sum of boxes (CDR-SOB) and the auditory verbal learning test
(AVLT) for cognitive measurement.
A problem that is often referred to as the curse of
dimensionality, where the large size (i.e., large number of
dimensions) of features for modeling AD progression makes it
difficult to perform various numerical analyses on the data. This
problem led to increased difficulty to draw consistent conclusions
from the dataset. The feature selection method addressed this
problem by leveraging the sparse learning technique to model
the AD progressive and predict AD progression using the
temporal priors and hippocampus. Apart from feature selection,
the clinical model and statistical analysis extracted diagnostic
information and learned large-scale medical imaging based on
features. By merging fused multi-task learning together with
the temporal smoothing of the parametric hippocampus surface,
clinical scores, and subjects, promising prediction results for
future ADAS-Cog and MMSE prediction were obtained.
The main challenge is to identify task-specific features and
significant biomarkers to model AD, as well as locating a
common set of features using the learned model. Previous works
showed that performance decreases with a smaller training set
(Stonnington et al., 2010), but the trend and relative performance
remain comparable. An interesting direction is to add constraints
to find similar parametric surfacesto determine more similar and
smoother weights, and hence better and more consistent results
can be obtained. This work illustrated that the extraction of the
volumetric information from parametric surface could aid in
the prediction of AD progression, which could be also extended
to fMRI studies. Because the dimensionality problem still exists
when the number of voxel and vertex points increases, feature
selection is generally a plausible approach to leverage prior
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information and explore sparsity and smoothness as well. Sparse
learning is a powerful tool to identify useful features and reduce
feature dimension. Although there are a number of feature
selection algorithms available, the features from these algorithms
often lack biological meanings and reasonable interpretations.
A method that is capable of locating desirable features with
reasonable feature dimension is highly desirable.
Directions for future work include understanding the
behavior of weights across the parametric surface space and
time. Previous works shown that stability selection (Zhou
et al., 2013) may be a good fit for analyzing the feature
weights on the model. Future works including the stability
analysis of weights which might provide more information
on the relationship between the deformation of hippocampal
subfields and other clinical indicators, such as AVLT during AD
progression. The longitudinal information on brain structure is
highly correlated to disease progression. Hippocampal atrophic
rates and ventricular changes are assessed statistically with the
surface change. The resulting maps are sensitive to longitudinal
changes in brain structure as the disease progresses. Additional
maps to localize atrophic change regions are linked to cognitive
decline. Additional maps for hippocampal atrophy and clinical
deterioration are also helpful for understanding AD progression.
These quantitative, dynamic visualizations of hippocampal
atrophy and ventricular expansion rates in aging and AD may
provide a promising measure to track AD progression in drug
trials. Furthermore, it would be interesting to investigate the
feasibility of extending our joint learning method to model and
predict other diseases, such as Parkinson’s disease or Autism
disorder.
In this paper, we proposed a novel longitudinal prediction
model which incorporates multiple relation information of data
in a unified objective function. We applied our proposed model
for AD progression prediction at multiple future time points,
using the baseline data only. Specifically, we developed a novel
multi-task sparse feature selection model by considering the
relationships between features, subjects, and clinical scores. The
feature selection procedure selects the most relevant features
for the task of clinical scores prediction at multiple future
time points, followed by the use of regression models for
predictions. Our experimental results of the proposed method
based on the ADNI database demonstrated promising results in
estimating the clinical cognitive scores at multiple future time
points.
AUTHOR CONTRIBUTIONS
BL, FJ, SC, DN, and TW designed the experiments; BL and DN
performed the data analysis and experiments; BL wrote the main
manuscript text; SC and TW provided scientific interpretation;
BL, FJ, SC, DN, and TW reviewed the manuscript, provided final
approval of the version to be published and ensured the accuracy
and integrity of the work.
ACKNOWLEDGMENTS
This work was supported partly by National Natural Science
Foundation of China (Nos. 61402296, 61571304, 81571758,
61501305, 61571304, and 61427806), National Key Research
and Develop Program (No. 2016YFC0104703), (Key) Project
of Department of Education of Guangdong Province (No.
2014GKXM052), Shenzhen Key Basic Research Project
(Nos. JCYJ20150525092940986, JCYJ20150525092940982,
and JCYJ20140509172609164), Guangdong Medical Grant (No.
B2016094), and the Open Fund Project of Fujian Provincial Key
Laboratory of Information Processing and Intelligent Control
(Minjiang University) (No.MJUKF201711), the National Natural
Science Foundation of Shenzhen University (No. 2016077). Data
collection and sharing for this project was funded by the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National
Institutes of Health Grant U01 AG024904) and DOD ADNI
(Department of Defense award number W81XWH-12-2-0012).
ADNI is funded by the National Institute on Aging, the National
Institute of Biomedical Imaging and Bioengineering.
REFERENCES
Alzheimer’s Association (2014). 2014 Alzheimer’s disease facts and figures.
Alzheimers Dement. 10, e47–e92. doi: 10.1016/j.jalz.2014.02.001
Belkin, M., and Niyogi, P. (2003). Laplacian eigenmaps for dimensionality
reduction and data representation. Neural Comput. 15, 1373–1396.
doi: 10.1162/089976603321780317
Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H. M. (2007).
Forecasting the global burden of Alzheimer’s disease. Alzheimer’s Dement. 3,
186–191. doi: 10.1016/j.jalz.2007.04.381
Caroli, A., and Frisoni, G. B. (2010). The dynamics of Alzheimer’s disease
biomarkers in the Alzheimer’s Disease neuroimaging initiative cohort.
Neurobiol. Aging 31, 1263–1274. doi: 10.1016/j.neurobiolaging.2010.04.024
Chang, C.-C., and Lin, C.-J. (2011). LIBSVM: a library for support vectormachines.
ACM Trans. Intell. Syst. Technol. 2, 1–27. doi: 10.1145/1961189.1961199
Convit, A., de Asis, J., de Leon, M. J., Tarshish, C. Y., De Santi, S., and Rusinek, H.
(2000). Atrophy of the medial occipitotemporal, inferior, and middle temporal
gyri in non-demented elderly predict decline to Alzheimer’s disease. Neurobiol.
Aging 21, 19–26. doi: 10.1016/S0197-4580(99)00107-4
Cuingnet, R., Gerardin, E., Tessieras, J., Auzias, G., Lehéricy, S., Habert,
M.-O., et al. (2011). Automatic classification of patients with Alzheimer’s
disease from structural MRI: a comparison of ten methods using the
ADNI database. Neuroimage 56, 766–781. doi: 10.1016/j.neuroimage.2010.
06.013
Daianu, M., Mendez, M. F., Baboyan, V. G., Jin, J., Melrose, R. J., Jimenez, E.
E., et al. (2016). An advanced white matter tract analysis in frontotemporal
dementia and early-onset Alzheimer’s disease. Brain Imaging Behav. 10,
1038–1053. doi: 10.1007/s11682-015-9458-5
Davatzikos, C., Bhatt, P., Shaw, L. M., Batmanghelich, K. N., and Trojanowski,
J. Q. (2010). Prediction of MCI to AD conversion, via MRI, CSF
biomarkers, and pattern classification.Neurobiol. Aging 32, 2322.e19–2322.e27.
doi: 10.1016/j.neurobiolaging.2010.05.023
Davatzikos, C., Fan, Y., Wu, X., Shen, D., and Resnick, S. M. (2008).
Detection of prodromal Alzheimer’s disease via pattern classification
of magnetic resonance imaging. Neurobiol. Aging 29, 514–523.
doi: 10.1016/j.neurobiolaging.2006.11.010
Davatzikos, C., Genc, A., Xu, D., and Resnick, S. M. (2001). Voxel-
based morphometry using the RAVENS Maps: methods and validation
Frontiers in Aging Neuroscience | www.frontiersin.org 15 March 2017 | Volume 9 | Article 6
Lei et al. Longitudinal Analysis for Disease Progression
using simulated longitudinal atrophy. Neuroimage 14, 1361–1369.
doi: 10.1006/nimg.2001.0937
Del Sole, A., Clerici, F., Chiti, A., Lecchi, M., Mariani, C., Maggiore, L., et al. (2008).
Individual cerebral metabolic deficits in Alzheimer’s disease and amnestic mild
cognitive impairment: an FDG PET study. Eur. J. Nucl. Med. Mol. Imaging 35,
1357–1366. doi: 10.1007/s00259-008-0773-6
Derflinger, S., Sorg, C., Gaser, C., Myers, N., Arsic, M., Kurz, A., et al.
(2011). Grey-matter atrophy in Alzheimer’s disease is asymmetric but
not lateralized. J. Alzheimers Dis. 25, 347–357. doi: 10.3233/JAD-2011-
110041
Dickerson, B. C., Goncharova, I., Sullivan, M. P., Forchetti, C., Wilson, R. S.,
Bennett, D. A., et al. (2001). MRI-derived entorhinal and hippocampal atrophy
in incipient and very mild Alzheimer’s disease. Neurobiol. Aging 22, 747–754.
doi: 10.1016/S0197-4580(01)00271-8
Duchesne, S., Caroli, A., Geroldi, C., Collins, D. L., and Frisoni, G.
B. (2009). Relating one-year cognitive change in mild cognitive
impairment to baseline MRI features. Neuroimage 47, 1363–1370.
doi: 10.1016/j.neuroimage.2009.04.023
Fan, Y., Resnick, S. M., Wu, X., and Davatzikos, C. (2008). Structural
and functional biomarkers of prodromal Alzheimer’s disease: a high-
dimensional pattern classification study. Neuroimage 41, 277–285.
doi: 10.1016/j.neuroimage.2008.02.043
Frisoni, G. B., Fox, N. C., Jack C. R. Jr., Scheltens, P., and Thompson, P. M. (2010).
The clinical use of structural MRI in Alzheimer disease. Nat. Rev. Neurol. 6,
67–77. doi: 10.1038/nrneurol.2009.215
Gaser, C., Nenadic, I., Buchsbaum, B. R., Hazlett, E. A., and Buchsbaum, M.
S. (2001). Deformation-based morphometry and its relation to conventional
volumetry of brain lateral ventricles in MRI. Neuroimage 13, 1140–1145.
doi: 10.1006/nimg.2001.0771
Guyon, I., and Elisseeff, A. (2003). An introduction to variable and feature
selection. J. Mach. Learn. Res. 3, 1157–1182. doi: 10.1162/153244303322753616
Guyon, I., Weston, J., Barnhill, S., and Vapnik, V. (2002). Gene selection for
cancer classification using support vector machines.Mach. Learn. 46, 389–422.
doi: 10.1023/A:1012487302797
Hinrichs, C., Singh, V., Mukherjee, L., Xu, G., Chung, M. K., and Johnson,
S. C. (2009). Spatially augmented LPboosting for AD classification
with evaluations on the ADNI dataset. Neuroimage 48, 138–149.
doi: 10.1016/j.neuroimage.2009.05.056
Hinrichs, C., Singh, V., Xu, G., and Johnson, S. C. (2011). Predictive
markers for AD in a multi-modality framework: an analysis of
MCI progression in the ADNI population. Neuroimage 55, 574–589.
doi: 10.1016/j.neuroimage.2010.10.081
Huang, L., Gao, Y., Jin, J., Thung, K.-H., Shen, D., and Alzheimer’s Disease
Neuroimaging Initiative. (2015). “Sparse regression based random forest for
predicting future clinical scores of Alzheimer’s disease,” in 6th International
Conference on Machine Learning in Medical Imaging, LNCS 9532 (Munich),
246–254.
Huang, L., Jin, Y., Gao, Y., Thung, K.-H., and Shen, D. (2016). Longitudinal
clinical score prediction in Alzheimer’s disease with soft-split sparse
regression based random forest. Neurobiol. Aging 46, 180–191.
doi: 10.1016/j.neurobiolaging.2016.07.005
Ito, K., Ahadieh, S., Corrigan, B., French, J., Fullerton, T., and Tensfeldt, T. (2010).
Disease progression meta-analysis model in Alzheimer’s disease. Alzheimer’s
Dement. 6, 39–53. doi: 10.1016/j.jalz.2009.05.665
Jack, C. R. Jr., Bernstein, M. A., Fox, N. C., Thompson, P., Alexander, G.,
Harvey, D., et al. (2008). The Alzheimer’s Disease Neuroimaging Initiative
(ADNI): MRImethods. J. Magn. Reson. Imaging 27, 685–691. doi: 10.1002/jmri.
21049
Jack C. R. Jr., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen,
P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic
biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol. 9, 119–128.
doi: 10.1016/S1474-4422(09)70299-6
Jie, B., Zhang, D., Cheng, B., and Shen, D. (2015). Manifold regularized multitask
feature learning for multimodality disease classification. Hum. Brain Mapp. 36,
489–507. doi: 10.1002/hbm.22642
Jin, Y., Huang, C., Daianu, M., Zhan, L., Dennis, E. L., Reid, R. I., et al. (2017). 3D
tract-specific local and global analysis of white matter integrity in Alzheimer’s
disease. Hum. Brain Mapp. doi: 10.1002/hbm.23448. [Epub ahead of print].
Jin, Y., Shi, Y., Zhan, L., and Thompson, P. M. (2015). “Automated multi-
atlas labeling of the fornix and its integrity in Alzheimer’s disease,” in IEEE
12th International Symposium on Biomedical Imaging (Brooklyn Bridge, NY),
140–143.
Knafo, S., Venero, C., Merino-Serrais, P., Fernaud-Espinosa, I., Gonzalez-Soriano,
J., Ferrer, I., et al. (2009). Morphological alterations to neurons of the amygdala
and impaired fear conditioning in a transgenic mouse model of Alzheimer’s
disease. J. Pathol. 219, 41–51. doi: 10.1002/path.2565
Laakso,M. P., Frisoni, G. B., Könönen,M.,Mikkonen,M., Beltramello, A., Geroldi,
C., et al. (2000). Hippocampus and entorhinal cortex in frontotemporal
dementia and Alzheimer’s disease: a morphometric MRI study. Biol. Psychiatry
47, 1056–1063. doi: 10.1016/S0006-3223(99)00306-6
Lei, B., Chen, S., Ni, D., and Wang, T. (2016). Discriminative learning
for Alzheimer’s Disease diagnosis via canonical correlation analysis and
multimodal fusion. Front. Aging Neurosci. 8:77. doi: 10.3389/fnagi.2016.
00077
Lei, B., Ni, D., Chen, S., and Wang, T. (2015a). “Joint learning of
multiple longitudinal prediction models by exploring internal relations,”
in Machine Learning in Medical Imaging, eds L. Zhou, L. Wang, Q.
Wang, and Y. Shi (Springer International Publishing), 9352, 330–337.
doi: 10.1007/978-3-319-24888-2_40
Lei, B., Yao, Y., Chen, S., Li, S., Li, W., Ni, D., et al. (2015b). Discriminative learning
for automatic staging of placental maturity via multi-layer fisher vector. Sci.
Rep. 5:12818. doi: 10.1038/srep12818
Leow, A. D., Klunder, A. D., Jack, C. R. Jr., Toga, A. W., Dale, A. M.,
Bernstein, M. A., et al. (2006). Longitudinal stability of MRI for mapping
brain change using tensor-based morphometry. Neuroimage 31, 627–640.
doi: 10.1016/j.neuroimage.2005.12.013
Liu, F., Wee, C.-Y., Chen, H., and Shen, D. (2014). Inter-modality relationship
constrainedmulti-modality multi-task feature selection for Alzheimer’s Disease
and mild cognitive impairment identification. Neuroimage 84, 466–475.
doi: 10.1016/j.neuroimage.2013.09.015
Liu, M., Zhang, D., and Shen, D. (2012). Ensemble sparse
classification of Alzheimer’s disease. Neuroimage 60, 1106–1116.
doi: 10.1016/j.neuroimage.2012.01.055
Liu, M., Zhang, D., and Shen, D. (2014). Hierarchical fusion of features and
classifier decisions for Alzheimer’s disease diagnosis. Hum. Brain Mapp. 35,
1305–1319. doi: 10.1002/hbm.22254
Liu, M., Zhang, D., and Shen, D. (2015). View-centralized multi-atlas classification
for Alzheimer’s disease diagnosis. Hum. Brain Mapp. 36, 1847–1865.
doi: 10.1002/hbm.22741
Misra, C., Fan, Y., and Davatzikos, C. (2009). Baseline and longitudinal patterns
of brain atrophy in MCI patients, and their use in prediction of short-
term conversion to AD: results from ADNI. Neuroimage 44, 1415–1422.
doi: 10.1016/j.neuroimage.2008.10.031
Ota, K., Oishi, N., Ito, K., and Fukuyama, H. (2014). A comparison of
three brain atlases for MCI prediction. J. Neurosci. Methods 221, 139–150.
doi: 10.1016/j.jneumeth.2013.10.003
Poulin, S. P., Dautoff, R., Morris, J. C., Barrett, L. F., and Dickerson,
B. C. (2011). Amygdala atrophy is prominent in early Alzheimer’s
disease and relates to symptom severity. Psychiatry Res. 194, 7–13.
doi: 10.1016/j.pscychresns.2011.06.014
Shen, D., and Davatzikos, C. (2002). HAMMER: hierarchical attribute matching
mechanism for elastic registration. IEEE Trans. Med. Imaging 21, 1421–1439.
doi: 10.1109/TMI.2002.803111
Shi, L., Zhao, L., Wong, A., Wang, D., and Mok, V. (2015). Mapping the
relationship of contributing factors for preclinical Alzheimer’s Disease. Sci. Rep.
5:11259. doi: 10.1038/srep11259
Stanciu, S. G., Xu, S., Peng, Q., Yan, J., Stanciu, G. A., Welsch, R. E.,
et al. (2014). Experimenting liver fibrosis diagnostic by two photon
excitation microscopy and bag-of-features image classification. Sci. Rep. 4:4636.
doi: 10.1038/srep04636
Stonnington, C. M., Chu, C., Klöppel, S., Jack, C. R. Jr., Ashburner, J.,
and Frackowiak, R. S. (2010). Predicting clinical scores from magnetic
resonance scans in Alzheimer’s disease. Neuroimage 51, 1405–1413.
doi: 10.1016/j.neuroimage.2010.03.051
Teipel, S. J., Born, C., Ewers, M., Bokde, A. L., Reiser, M. F., Möller H.-J., et al.
(2007). Multivariate deformation-based analysis of brain atrophy to predict
Frontiers in Aging Neuroscience | www.frontiersin.org 16 March 2017 | Volume 9 | Article 6
Lei et al. Longitudinal Analysis for Disease Progression
Alzheimer’s disease in mild cognitive impairment. Neuroimage 38, 13–24.
doi: 10.1016/j.neuroimage.2007.07.008
Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. J. R. Stat.
Soc. B 58, 267–288.
Vemuri, P., Gunter, J. L., Senjem, M. L., Whitwell, J. L., Kantarci, K., Knopman,
D. S., et al. (2008). Alzheimer’s disease diagnosis in individual subjects
using structural MR images: validation studies. Neuroimage 39, 1186–1197.
doi: 10.1016/j.neuroimage.2007.09.073
Vemuri, P., Wiste, H. J., Weigand, S. D., Shaw, L. M., Trojanowski, J. Q.,
Weiner, M. W., et al. (2009). MRI and CSF biomarkers in normal, MCI,
and AD subjects: predicting future clinical change. Neurol 73, 294–301.
doi: 10.1212/WNL.0b013e3181af79fb
Wang, H., Nie, F., Huang, H., Yan, J., Kim, S., Risacher, S., et al. (2012). High-
order multi-task feature learning to identify longitudinal phenotypic markers
for alzheimer’s disease progression prediction. Adv. Neural Inf. Process. Syst. 2,
1277–1285.
Wang, Y., Fan, Y., Bhatt, P., and Davatzikos, C. (2010). High-dimensional pattern
regression using machine learning: from medical images to continuous clinical
variables. Neuroimage 50, 1519–1535. doi: 10.1016/j.neuroimage.2009.12.092
Wang, T., Shi, F., Jin, Y., Jiang, W., Shen, D., and Xiao, S. (2016a).
Abnormal changes of brain cortical anatomy and the association with plasma
microRNA107 level in amnestic mild cognitive impairment. Front. Aging
Neurosci. 8:112. doi: 10.3389/fnagi.2016.00112
Wang, T., Shi, F., Jin, Y., Yap, P.-T., Wee, C.-Y., Zhang, J., et al. (2016b). Multilevel
deficiency of white matter connectivity networks in Alzheimer’s disease: a
diffusionMRI study with DTI and HARDI models.Neural Plast. 2016:2947136.
doi: 10.1155/2016/2947136
Wang, Y., Nie, J., Yap, P.-T., Li, G., Shi, F., Geng, X., et al. (2014).
Alzheimer’s Disease neuroimaging initiative. Knowledge-guided robust mri
brain extraction for diverse large-scale neuroimaging studies on humans and
non-human primates. PLoS ONE 9:e77810. doi: 10.1371/journal.pone.0077810
Wee, C. Y., Yap, P. T., Zhang, D., Denny, K., Browndyke, J. N., Potter,
G. G., et al. (2012). Identification of MCI individuals using structural
and functional connectivity networks. Neuroimage 59, 2045–2056.
doi: 10.1016/j.neuroimage.2011.10.015
Wolf, H., Jelic, V., Gertz, H. J., Nordberg, A., Julin, P., and Wahlund, L. O. (2003).
A critical discussion of the role of neuroimaging in mild cognitive impairment.
Acta Neurol. Scand. 107, 52–76. doi: 10.1034/j.1600-0404.107.s179.10.x
Wu, H., Chen, G., Jin, Y., Shen, D., and Yap, P.-T. (2016). Embarrassingly parallel
acceleration of global tractography via dynamic domain partitioning. Front.
Neuroinform. 10:25. doi: 10.3389/fninf.2016.00025
Yang, X., Jin, Y., Chen, X., Zhang, H., Li, G., and Shen, D. (2016). “Functional
connectivity network fusion with dynamic thresholding for MCI diagnosis,” in
7th International Conference on Machine Learning in Medical Imaging, LNCS
10019 (Athens), 246–253.
Yuan, M., and Lin, Y. (2006). Model selection and estimation in
regression with grouped variables. J. R. Stat. Soc. B 68, 49–67.
doi: 10.1111/j.1467-9868.2005.00532.x
Zhang, D., Liu, J., and Shen, D. (2012). “Temporally-constrained group sparse
learning for longitudinal data analysis,” in Medical Image Computing and
Computer-Assisted Intervention - MICCAI 2012, eds N. Ayache, H. Delingette,
P. Golland, and K. Mori (Berlin; Heidelberg: Springer), 7512, 264–271.
doi: 10.1007/978-3-642-33454-2_33
Zhang, D., and Shen, D. (2012). Alzheimer’s Disease neuroimaging
initiative. Predicting future clinical changes of MCI patients using
longitudinal and multimodal biomarkers. PLoS ONE 7:e33182.
doi: 10.1371/journal.pone.0033182
Zhang, D., Wang, Y., Zhou, L., Yuan, H., and Shen, D. (2011). Multimodal
classification of Alzheimer’s disease and mild cognitive impairment.
Neuroimage 55, 856–867. doi: 10.1016/j.neuroimage.2011.01.008
Zhang, Y., Brady, M., and Smith, S. (2001). Segmentation of brain
MR images through a hidden Markov random field model and the
expectation-maximization algorithm. IEEE Trans. Med. Imaging 20, 45–57.
doi: 10.1109/42.906424
Zhou, F., Jiao, J., and Lei, B. (2015). A linear threshold-hurdle model for product
adoption prediction incorporating social network effects. Inf. Sci. 307, 95–109.
doi: 10.1016/j.ins.2015.02.027
Zhou, J., Liu, J., Narayan, V. A., and Ye, J. (2013). Modeling disease
progression via multi-task learning. Neuroimage 78, 233–248.
doi: 10.1016/j.neuroimage.2013.03.073
Zhu, X., Suk, H. I., and Shen, D. (2014b). A novel multi-relation regularization
method for regression and classification in AD diagnosis. Med. Image
Comput. Comput. Assist. Intervent. 17, 401–408. doi: 10.1007/978-3-319-104
43-0_51
Zhu, X., Suk, H. I., and Shen, D. (2014a). A novel matrix-similarity based loss
function for joint regression and classification in AD diagnosis. Neuroimage
100, 91–105. doi: 10.1016/j.neuroimage.2014.05.078
Zhu, X., Wu, X., Ding, W., and Zhang, S. (2013). “Feature selection by joint
graph sparse coding,” in Proceedings of the 2013 SIAM International
Conference on Data Mining, 803–811. doi: 10.1137/1.978161197
2832.89
Zhuo, Y., Ni, D., Chen, S., Lei, B., and Wang, T. (2016). “Adaptive ensemble
manifold learning for neuroimaging retrieval,” in 13th International Symposium
on Biomedical Imaging (Prague), 859–862.
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Lei, Jiang, Chen, Ni and Wang. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Aging Neuroscience | www.frontiersin.org 17 March 2017 | Volume 9 | Article 6
